具有维生素E支架的可离子化脂质材料作为mRNA疫苗平台,用于有效的细胞毒性T细胞反应
Ryotaro Oyama1, Harumichi Ishigame2, Hiroki Tanaka3
1Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-0856, Japan.
ACS nano
|October 10, 2023
概括
新的脂质纳米粒子 (LNP) 与维生素E支架增强RNA疫苗. 这些疫苗有效诱导CD8+ T细胞反应,这对于通过向感染细胞来对抗感染和癌症至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 纳米技术纳米技术
背景情况:
- 使用脂质纳米粒子 (LNP) 的RNA疫苗是一种成功但仍在发展中的疫苗技术.
- RNA疫苗的一个关键优势是它们能够刺激CD8+T细胞介导免疫力,这对于消除感染或癌细胞至关重要.
研究的目的:
- 开发增强的LNP,以改善细胞免疫诱导.
- 研究一种具有维生素E支架的可电离脂在RNA疫苗疗效中的作用.
主要方法:
- 开发新型LNP,其中包含具有维生素E支架的电离性脂质.
- 封装在体外转录的mRNA (IVT-mRNA) 编码模型抗原 (卵胺,TgPF).
- 在瘤模型 (E.G7-OVA) 和传染病模型 (Toxoplasma gondii) 中评估疫苗的疗效.
主要成果:
- 用维生素E架构的RNA疫苗诱导了抗原特异性细胞毒性T细胞反应和抗瘤作用.
- 接种疫苗可以保护人免受致命的Toxoplasma gondii感染.
- 维生素E支架依赖的I型干扰素反应对CD8+T细胞分化至关重要.
- 传统的树突细胞 (cDCs),特别是cDC2,对于CD8+T细胞反应至关重要,而cDC1不需要.
结论:
- 开发的LNP可以通过RNA疫苗增强细胞免疫诱导.
- 通过维生素E支架的辅助活性和cDC2中的抗原表达,先天免疫激活对于强大的T细胞反应至关重要.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.